John T. Boris - SunTrust Robinson Humphrey
Last quote by John T. Boris
The delay also shaves off valuable time for Merck to establish itself as the immune-oncology standard-of-care in first-line non-small cell lung cancer patients.feedback
Oct 30 2017
“Anything that causes concern over those two assets would be reasons why people might consider selling.” said John T. Boris on this article: Lilly mulls sale, other options for animal health business. This page contains 3 articles quoting John T. Boris. Main topics on which John T. Boris is quoted are Pfizer and fit. In addition you’ll find 3 quotes there. All these quotes are mentioned on this page and you can filter them by date and by topics.
Take our quote verification challenge and find out !
Quotes by John T. Boris
Oct 24 2017
Anything that causes concern over those two assets would be reasons why people might consider selling.feedback
Oct 06 2016
They're not a strategic fit for Pfizer, which has been looking for a buyer.feedback
Check if the quote you read on social networks is authentic
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided